CFTR and cystic fibrosis: While primary HBECs remain the gold-standard assay for CF, iPSC-derived airway cells may accelerate this research by overcoming the bottleneck in accessing human cells carrying rare CFTR variants with ultimate validation of candidate therapeutics in HBECs.